{
  "id": 3066246,
  "title": "A case of Bundibugyo virus disease treated with monoclonal antibodies and remdesivir",
  "url": "https://urgent.news/2026/08/24/a-case-of-bundibugyo-virus-disease-treated-with-monoclonal-antibodies",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-24T00:00:00.000Z",
  "source": {
    "name": "Nature Medicine",
    "slug": "nature-medicine",
    "url": "https://www.nature.com/articles/s41591-026-04663-5"
  },
  "original_language": "en",
  "account": null,
  "summary": "Nature Medicine, Published online: 24 August 2026; doi:10.1038/s41591-026-04663-5 In a case report of an individual with Bundibugyo virus infection, treatment with emergency use of the monoclonal antibody cocktail MBP134 with remdesivir and supportive care treatment resulted in recovery and discharge 22 days after symptom onset, supporting further evaluation of MBP134.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Nature Medicine",
        "title": "Post-Exposure Prophylaxis with a monoclonal antibody cocktail Following Bundibugyo Ebolavirus Exposure in Adults and Children",
        "url": "https://urgent.news/2026/08/24/post-exposure-prophylaxis-with-a-monoclonal-antibody-cocktail",
        "published": "2026-08-24T00:00:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}